Erica Rappold
Erica Rappold publishes mostly in Oncology, Genetics and Pulmonary and Respiratory Medicine, on topics such as Chronic Lymphocytic Leukemia Research, HER2/EGFR in Cancer Research and Advanced Breast Cancer Therapies.
- World rank
- #2,064,204 of 7,710,434 ranked researchers
- Rank in United States
- #624,358 of 1,627,098
- Works
- 32
- Citations
- 1.5k
- Citations per work
- 46.2
What does Erica Rappold research?
Erica Rappold's work is mostly in Medicine (77%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2577.0%
- Medicine2577.0%
- Everything else617.8%
- Life Sciences25.2%
- 1Oncology32% of their works
- 2Genetics16% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Hematology8% of their works
- 5Pathology and Forensic Medicine7% of their works
- 6Molecular Biology5% of their works
Research topics
Which keywords describe Erica Rappold's research?
The keywords of their largest research topics: Breast Cancer, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, HER2, Trastuzumab, Metastatic Breast Cancer and CDK4/6 Inhibitors.
- Breast Tumours
- Targeted Therapy
- Chemotherapy-Induced Peripheral Neuropathy
- Imatinib
- BCR-ABL
- CDK4/6 Inhibitors
- Trastuzumab
- Genomic Aberrations
- Rituximab
- Breast Cancer
- Chronic Lymphocytic Leukemia
- HER2
- Metastatic Breast Cancer
- Palbociclib
- Classification
- Lymphoma
- EGFR Mutations
- Taxanes
- Gene Expression
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Breast Cancer222 topics
- Rituximab212 topics
- Chronic Lymphocytic Leukemia151 topic
- Genomic Aberrations151 topic
- HER2141 topic
- Trastuzumab141 topic
- Metastatic Breast Cancer132 topics
- CDK4/6 Inhibitors81 topic
- Palbociclib81 topic
- BCR-ABL61 topic
- Classification61 topic
- Imatinib61 topic
- Lymphoma61 topic
- Chemotherapy-Induced Peripheral Neuropathy51 topic
- EGFR Mutations51 topic
- Targeted Therapy51 topic
- Taxanes51 topic
- Breast Tumours41 topic
- Gene Expression41 topic
Where does Erica Rappold work?
Erica Rappold's main affiliation in the publication record is GlaxoSmithKline (United States), United States.
How many publications and citations does Erica Rappold have?
OpenAlex counts 32 works and 1,477 citations for Erica Rappold, an h-index of 12, ranking #2,064,204 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Erica Rappold. Posts are plain text and can be reported.